A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium

The Lancet Infectious Diseases

Volumn 15, Issue 1, 2015, Pages 85-94

  Checkley, William ^a,b   White, A Clinton ^c   Jaganath, Devan ^a   Arrowood, Michael J ^d   Chalmers, Rachel M ^e   Chen, Xian Ming ^f   Fayer, Ronald ^g   Griffiths, Jeffrey K ^h   Guerrant, Richard L ⁱ   Hedstrom, Lizbeth ^j   Huston, Christopher D ^k   Kotloff, Karen L ^l   Kang, Gagandeep ^m   Mead, Jan R ^n,o   Miller, Mark ^b   Petri, William A ⁱ   Priest, Jeffrey W ^d   Roos, David S ^p   Striepen, Boris ^q   Thompson, R C Andrew ^r   Ward, Honorine D ^s   Van Voorhis, Wesley A ^t   Xiao, Lihua ^d   Zhu, Guan ^u   Houpt, Eric R ⁱ   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e PUBLIC HEALTH WALES   (United Kingdom)

^f CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g U S DEPARTMENT OF AGRICULTURE   (United States)

^h TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

^j BRANDEIS UNIVERSITY   (United States)

^k UNIVERSITY OF VERMONT   (United States)

^l University of Maryland School of Medicine Center for Vaccine Development   (United States)

^m CHRISTIAN MEDICAL COLLEGE   (India)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o ATLANTA VA MEDICAL CENTER   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q UNIVERSITY OF GEORGIA   (United States)

^r MURDOCH UNIVERSITY   (Australia)

^s TUFTS MEDICAL CENTER   (United States)

^t UNIVERSITY OF WASHINGTON   (United States)

^u TEXAS A AND M UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; PROTOZOAL VACCINE; ANTIPROTOZOAL AGENT;

ANTIGEN DETECTION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; ENVIRONMENTAL FACTOR; FLUORESCENCE MICROSCOPY; GENETIC MANIPULATION; HORIZONTAL GENE TRANSFER; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO PROPAGATION; MORBIDITY; MORTALITY; NONHUMAN; NUCLEIC ACID ANALYSIS; PROTOZOAL GENETICS; REVIEW; SEROLOGY; DIAGNOSTIC TEST; DIARRHEA; HEALTH; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARASITOLOGY; PROCEDURES;

ANTIPROTOZOAL AGENTS; CRYPTOSPORIDIOSIS; DIAGNOSTIC TESTS, ROUTINE; DIARRHEA; GLOBAL HEALTH; HUMANS; PROTOZOAN VACCINES;

EID: 84918574823     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70772-8     Document Type: Review

References (150)

1. White AC Cryptosporidiosis and the ears of the hippopotamus. Clin Infect Dis 2010, 50:1373-1374.
2. Current WL, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N Engl J Med 1983, 308:1252-1257.
3. Soave R, Danner RL, Honig CL, et al. Cryptosporidiosis in homosexual men. Ann Intern Med 1984, 100:504-511.
4. D'Antonio RG, Winn RE, Taylor JP, et al. A waterborne outbreak of cryptosporidiosis in normal hosts. Ann Intern Med 1985, 103:886-888.
5. Sallon S, Deckelbaum RJ, Schmid II, Harlap S, Baras M, Spira DT Cryptosporidium, malnutrition, and chronic diarrhea in children. Am J Dis Child 1988, 142:312-315.
6. MacKenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994, 331:161-167.
7. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis 2011, 17:7-15.
8. Shirley DA, Moonah SN, Kotloff KL Burden of disease from cryptosporidiosis. Curr Opin Infect Dis 2012, 25:555-563.
9. Lima AA, Samie A, Guerrant RL Cryptosporidiosis. Tropical Infectious Diseases 2011, 640-663. Elsevier-Churchill Livingstone, Philadelphia, Pa. R.L. Guerrant, D.H. Walker, P.F. Weller (Eds.).
10. Samie A, Bessong PO, Obi CL, et al. Cryptosporidium species: preliminary descriptions of the prevalence and genotype distribution among school children and hospital patients in the Venda region, Limpopo Province, South Africa. Exp Parasitol 2006, 114:314-322.
11. Ajjampur SS, Rajendran P, Ramani S, et al. Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. J Med Microbiol 2008, 57:1364-1368.
12. Tumwine JK, Kekitiinwa A, Nabukeera N, et al. Cryptosporidium parvum in children with diarrhea in Mulago Hospital, Kampala, Uganda. Am J Trop Med Hyg 2003, 68:710-715.
13. Mor SM, Tzipori S Cryptosporidiosis in children in Sub-Saharan Africa: a lingering challenge. Clin Infect Dis 2008, 47:915-921.
14. Bern C, Ortega Y, Checkley W, et al. Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg Infect Dis 2002, 8:581-585.
15. Khan WA, Rogers KA, Karim MM, et al. Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. Am J Trop Med Hyg 2004, 71:412-419.
16. Lima AA, Moore SR, Barboza MS, et al. Persistent diarrhea signals a critical period of increased diarrhea burdens and nutritional shortfalls: a prospective cohort study among children in northeastern Brazil. J Infect Dis 2000, 181:1643-1651.
17. Moore SR, Lima NL, Soares AM, et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. Gastroenterology 2010, 139:1156-1164.
18. Ajjampur SS, Liakath FB, Kannan A, et al. Multisite study of cryptosporidiosis in children with diarrhea in India. J Clin Microbiol 2010, 48:2075-2081.
19. Checkley W, Epstein LD, Gilman RH, Black RE, Cabrera L, Sterling CR Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol 1998, 148:497-506.
20. Mølbak K, Andersen M, Aaby P, et al. Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr 1997, 65:149-152.
21. Agnew DG, Lima AA, Newman RD, et al. Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity. J Infect Dis 1998, 177:754-760.
22. Mondal D, Haque R, Sack RB, Kirkpatrick BD, Petri WA Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg 2009, 80:824-826.
23. Checkley W, Gilman RH, Epstein LD, et al. Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am J Epidemiol 1997, 145:156-163.
24. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 2013, 382:209-222.
25. Bouzid M, Hunter PR, Chalmers RM, Tyler KM Cryptosporidium pathogenicity and virulence. Clin Microbiol Rev 2013, 26:115-134.
26. Abrahamsen MS, Templeton TJ, Enomoto S, et al. Complete genome sequence of the apicomplexan. Cryptosporidium parvum. Science 2004, 304:441-445.
27. Xu P, Widmer G, Wang Y, et al. The genome of Cryptosporidium hominis. Nature 2004, 431:1107-1112.
28. Aurrecoechea C, Barreto A, Brestelli J, et al. EuPathDB: the eukaryotic pathogen database. Nucleic Acids Res 2013, 41:D684-D691.
29. Cama VA, Bern C, Roberts J, et al. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis 2008, 14:1567-1574.
30. Bushen OY, Kohli A, Pinkerton RC, et al. Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg 2007, 101:378-384.
31. Hira KG, Mackay MR, Hempstead AD, et al. Genetic diversity of Cryptosporidium spp. from Bangladeshi children. J Clin Microbiol 2011, 49:2307-2310.
32. Ajjampur SS, Sarkar R, Sankaran P, et al. Symptomatic and asymptomatic Cryptosporidium infections in children in a semi-urban slum community in southern India. Am J Trop Med Hyg 2010, 83:1110-1115.
33. Elwin K, Hadfield SJ, Robinson G, Chalmers RM The epidemiology of sporadic human infections with unusual cryptosporidia detected during routine typing in England and Wales, 2000-2008. Epidemiol Infect 2012, 140:673-683.
34. Nundy S, Gilman RH, Xiao L, et al. Wealth and its associations with enteric parasitic infections in a low-income community in Peru: use of principal component analysis. Am J Trop Med Hyg 2011, 84:38-42.
35. Sarkar R, Ajjampur SS, Prabakaran AD, et al. Cryptosporidiosis among children in an endemic semiurban community in southern India: does a protected drinking water source decrease infection?. Clin Infect Dis 2013, 57:398-406.
36. Muchiri JM, Ascolillo L, Mugambi M, et al. Seasonality of Cryptosporidium oocyst detection in surface waters of Meru, Kenya as determined by two isolation methods followed by PCR. J Water Health 2009, 7:67-75.
37. Jagai JS, Castronovo DA, Monchak J, Naumova EN Seasonality of cryptosporidiosis: A meta-analysis approach. Environ Res 2009, 109:465-478.
38. Mor SM, Tumwine JK, Ndeezi G, et al. Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission. Clin Infect Dis 2010, 50:1366-1372.
39. Mondal D, Minak J, Alam M, et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin Infect Dis 2012, 54:185-192.
40. Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four-seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 1999, 61:707-713.
41. Kirkpatrick BD, Daniels MM, Jean SS, et al. Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian children. J Infect Dis 2002, 186:94-101.
42. Carneiro-Filho BA, Bushen OY, Brito GA, Lima AA, Guerrant RL Glutamine analogues as adjunctive therapy for infectious diarrhea. Curr Infect Dis Rep 2003, 5:114-119.
43. Kirkpatrick BD, Haque R, Duggal P, et al. Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J Infect Dis 2008, 197:474-478.
44. Oriá RB, Patrick PD, Blackman JA, Lima AA, Guerrant RL Role of apolipoprotein E4 in protecting children against early childhood diarrhea outcomes and implications for later development. Med Hypotheses 2007, 68:1099-1107.
45. Arrowood MJ In vitro cultivation of cryptosporidium species. Clin Microbiol Rev 2002, 15:390-400.
46. Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J Med Microbiol 2011, 60:1598-1604.
47. Johnston SP, Ballard MM, Beach MJ, Causer L, Wilkins PP Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens. J Clin Microbiol 2003, 41:623-626.
48. Garcia LS, Shimizu RY Evaluation of nine immunoassay kits (enzyme immunoassay and direct fluorescence) for detection of Giardia lamblia and Cryptosporidium parvum in human fecal specimens. J Clin Microbiol 1997, 35:1526-1529.
49. Robinson TJ, Cebelinski EA, Taylor C, Smith KE Evaluation of the positive predictive value of rapid assays used by clinical laboratories in Minnesota for the diagnosis of cryptosporidiosis. Clin Infect Dis 2010, 50:e53-e55.
50. Hadfield SJ, Robinson G, Elwin K, Chalmers RM Detection and differentiation of Cryptosporidium spp. in human clinical samples by use of real-time PCR. J Clin Microbiol 2011, 49:918-924.
51. Elwin K, Robinson G, Hadfield SJ, Fairclough HV, Iturriza-Gómara M, Chalmers RM A comparison of two approaches to extracting Cryptosporidium DNA from human stools as measured by a real-time PCR assay. J Microbiol Methods 2012, 89:38-40.
52. Youn S, Kabir M, Haque R, Petri WA Evaluation of a screening test for detection of giardia and cryptosporidium parasites. J Clin Microbiol 2009, 47:451-452.
53. Agnamey P, Sarfati C, Pinel C, et al. Evaluation of four commercial rapid immunochromatographic assays for detection of Cryptosporidium antigens in stool samples: a blind multicenter trial. J Clin Microbiol 2011, 49:1605-1607. the ANOFEL Cryptosporidium National Network.
54. Stroup SE, Roy S, Mchele J, et al. Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes. J Med Microbiol 2006, 55:1217-1222.
55. Jiang J, Xiao L An evaluation of molecular diagnostic tools for the detection and differentiation of human-pathogenic Cryptosporidium spp. J Eukaryot Microbiol 2003, 50(suppl):542-547.
56. Jothikumar N, da Silva AJ, Moura I, Qvarnstrom Y, Hill VR Detection and differentiation of Cryptosporidium hominis and Cryptosporidium parvum by dual TaqMan assays. J Med Microbiol 2008, 57:1099-1105.
57. Mazurie AJ, Alves JM, Ozaki LS, Zhou S, Schwartz DC, Buck GA Comparative genomics of Cryptosporidium. Int J Genomics 2013, 2013:832756.
58. Xiao L, Ryan UM Cryptosporidiosis: an update in molecular epidemiology. Curr Opin Infect Dis 2004, 17:483-490.
59. Robinson G, Chalmers RM Assessment of polymorphic genetic markers for multi-locus typing of Cryptosporidium parvum and Cryptosporidium hominis. Exp Parasitol 2012, 132:200-215.
60. Stroup S, Tongjai S, Swai N, Maro A, Kibiki G, Houpt ER Dual probe DNA capture for sensitive real-time PCR detection of Cryptosporidium and Giardia. Mol Cell Probes 2012, 26:104-106.
61. Crannell ZA, Castellanos-Gonzalez A, Irani A, Rohrman B, White AC, Richards-Kortum R Nucleic acid test to diagnose cryptosporidiosis: lab assessment in animal and patient specimens. Anal Chem 2014, 86:2565-2571.
62. Taniuchi M, Sobuz SU, Begum S, et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis 2013, 208:1794-1802.
63. Goodgame RW, Kimball K, Ou CN, et al. Intestinal function and injury in acquired immunodeficiency syndrome-related cryptosporidiosis. Gastroenterology 1995, 108:1075-1082.
64. Priest JW, Bern C, Xiao L, et al. Longitudinal analysis of cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin Vaccine Immunol 2006, 13:123-131.
65. Lammie PJ, Moss DM, Brook Goodhew E, et al. Development of a new platform for neglected tropical disease surveillance. Int J Parasitol 2012, 42:797-800.
66. Griffin SM, Chen IM, Fout GS, Wade TJ, Egorov AI Development of a multiplex microsphere immunoassay for the quantitation of salivary antibody responses to selected waterborne pathogens. J Immunol Methods 2011, 364:83-93.
67. Cabada MM, White AC Treatment of cryptosporidiosis: do we know what we think we know?. Curr Opin Infect Dis 2010, 23:494-499.
68. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medical Association of the Infectious Diseases Society of America [cited 2013 May 7] Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, (accessed April 1, 2014). http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
69. Dillingham RA, Pinkerton R, Leger P, et al. High early mortality in patients with chronic acquired immunodeficiency syndrome diarrhea initiating antiretroviral therapy in Haiti: a case-control study. Am J Trop Med Hyg 2009, 80:1060-1064.
70. Rossignol JF, Ayoub A, Ayers MS Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis 2001, 184:103-106.
71. Rossignol JF, Kabil SM, el-Gohary Y, Younis AM Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol 2006, 4:320-324.
72. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 2002, 360:1375-1380.
73. Rossignol JF, Hidalgo H, Feregrino M, et al. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico. Trans R Soc Trop Med Hyg 1998, 92:663-666.
74. Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 2009, 9:195.
75. White AC, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis 1994, 170:419-424.
76. Hewitt RG, Yiannoutsos CT, Higgs ES, et al. Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. Clin Infect Dis 2000, 31:1084-1092. the AIDS Clinical Trial Group.
77. Giacometti A, Cirioni O, Barchiesi F, Ancarani F, Scalise G Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. J Antimicrob Chemother 2000, 45:453-456.
78. Magariños MP, Carmona SJ, Crowther GJ, et al. TDR Targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res 2012, 40:D1118-D1127.
79. Agüero F, Al-Lazikani B, Aslett M, et al. Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov 2008, 7:900-907.
80. Murphy RC, Ojo KK, Larson ET, et al. Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondii. ACS Med Chem Lett 2010, 1:331-335.
81. Larson ET, Ojo KK, Murphy RC, et al. Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. J Med Chem 2012, 55:2803-2810.
82. Zhang Z, Ojo KK, Johnson SM, et al. Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1. Bioorg Med Chem Lett 2012, 22:5264-5267.
83. Castellanos-Gonzalez A, White AC, Ojo KK, et al. A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosis. J Infect Dis 2013, 208:1342-1348.
84. Arrowood MJ, Mead JR, Xie L, You X In vitro anticryptosporidial activity of dinitroaniline herbicides. FEMS Microbiol Lett 1996, 136:245-249.
85. Armson A, Sargent K, MacDonald LM, Finn MP, Thompson RC, Reynoldson JA A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats. FEMS Immunol Med Microbiol 1999, 26:109-113.
86. Armson A, Meloni BP, Reynoldson JA, Thompson RC Assessment of drugs against Cryptosporidium parvum using a simple in vitro screening method. FEMS Microbiol Lett 1999, 178:227-233.
87. Rider SD, Zhu G Cryptosporidium: genomic and biochemical features. Exp Parasitol 2010, 124:2-9.
88. Madern D, Cai X, Abrahamsen MS, Zhu G Evolution of Cryptosporidium parvum lactate dehydrogenase from malate dehydrogenase by a very recent event of gene duplication. Mol Biol Evol 2004, 21:489-497.
89. Cai X, Herschap D, Zhu G Functional characterization of an evolutionarily distinct phosphopantetheinyl transferase in the apicomplexan Cryptosporidium parvum. Eukaryot Cell 2005, 4:1211-1220.
90. Zeng B, Cai X, Zhu G Functional characterization of a fatty acyl-CoA-binding protein (ACBP) from the apicomplexan Cryptosporidium parvum. Microbiology 2006, 152:2355-2363.
91. Fritzler JM, Zhu G Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP). J Antimicrob Chemother 2012, 67:609-617.
92. Fritzler JM, Zhu G Functional characterization of the acyl-[acyl carrier protein] ligase in the Cryptosporidium parvum giant polyketide synthase. Int J Parasitol 2007, 37:307-316.
93. Guo F, Zhang H, Fritzler JM, et al. Amelioration of Cryptosporidium parvum infection in vitro and in vivo by targeting parasite fatty acyl-coenzyme A synthetases. J Infect Dis 2014, 209:1279-1287.
94. Ndao M, Nath-Chowdhury M, Sajid M, et al. A cysteine protease inhibitor rescues mice from a lethal Cryptosporidium parvum infection. Antimicrob Agents Chemother 2013, 57:6063-6073.
95. Striepen B, Pruijssers AJ, Huang J, et al. Gene transfer in the evolution of parasite nucleotide biosynthesis. Proc Natl Acad Sci USA 2004, 101:3154-3159.
96. Huang J, Mullapudi N, Lancto CA, Scott M, Abrahamsen MS, Kissinger JC Phylogenomic evidence supports past endosymbiosis, intracellular and horizontal gene transfer in Cryptosporidium parvum. Genome Biol 2004, 5:R88.
97. Striepen B, White MW, Li C, et al. Genetic complementation in apicomplexan parasites. Proc Natl Acad Sci USA 2002, 99:6304-6309.
98. Umejiego NN, Gollapalli D, Sharling L, et al. Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis. Chem Biol 2008, 15:70-77.
99. Kirubakaran S, Gorla SK, Sharling L, et al. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH. Bioorg Med Chem Lett 2012, 22:1985-1988.
100. Gorla SK, Kavitha M, Zhang M, et al. Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. J Med Chem 2013, 56:4028-4043.
101. Maurya SK, Gollapalli DR, Kirubakaran S, et al. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase. J Med Chem 2009, 52:4623-4630.
102. Sharling L, Liu X, Gollapalli DR, Maurya SK, Hedstrom L, Striepen B A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase. PLoS Negl Trop Dis 2010, 4:e794.
103. Gorla SK, McNair NN, Yang G, et al. Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis. Antimicrob Agents Chemother 2014, 58:1603-1614.
104. Bessoff K, Sateriale A, Lee KK, Huston CD Drug repurposing screen reveals FDA-approved inhibitors of human HMG-CoA reductase and isoprenoid synthesis that block Cryptosporidium parvum growth. Antimicrob Agents Chemother 2013, 57:1804-1814.
105. Mead JR Challenges and prospects for a Cryptosporidium vaccine. Future Microbiol 2010, 5:335-337.
106. Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 1998, 66:441-443.
107. Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg 1999, 60:157-164.
108. Pantenburg B, Dann SM, Wang HC, et al. Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun 2008, 76:23-29.
109. Borad A, Ward H Human immune responses in cryptosporidiosis. Future Microbiol 2010, 5:507-519.
110. Carmolli M, Duggal P, Haque R, et al. Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. J Infect Dis 2009, 200:1540-1547.
111. Kirkpatrick BD, Huston CD, Wagner D, et al. Serum mannose-binding lectin deficiency is associated with cryptosporidiosis in young Haitian children. Clin Infect Dis 2006, 43:289-294.
112. Kelly P, Jack DL, Naeem A, et al. Mannose-binding lectin is a component of innate mucosal defense against Cryptosporidium parvum in AIDS. Gastroenterology 2000, 119:1236-1242.
113. Petry F, Jakobi V, Wagner S, Tessema TS, Thiel S, Loos M Binding and activation of human and mouse complement by Cryptosporidium parvum (Apicomplexa) and susceptibility of C1q- and MBL-deficient mice to infection. Mol Immunol 2008, 45:3392-3400.
114. Carryn S, Schaefer DA, Imboden M, Homan EJ, Bremel RD, Riggs MW Phospholipases and cationic peptides inhibit Cryptosporidium parvum sporozoite infectivity by parasiticidal and non-parasiticidal mechanisms. J Parasitol 2012, 98:199-204.
115. Zaalouk TK, Bajaj-Elliott M, George JT, McDonald V Differential regulation of beta-defensin gene expression during Cryptosporidium parvum infection. Infect Immun 2004, 72:2772-2779.
116. Chen XM, O'Hara SP, Nelson JB, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB. J Immunol 2005, 175:7447-7456.
117. Hu G, Gong AY, Roth AL, et al. Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog 2013, 9:e1003261.
118. Chen XM, Splinter PL, O'Hara SP, LaRusso NF A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 2007, 282:28929-28938.
119. Gong AY, Hu G, Zhou R, et al. MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int J Parasitol 2011, 41:397-403.
120. Hu G, Zhou R, Liu J, Gong AY, Chen XM MicroRNA-98 and let-7 regulate expression of suppressor of cytokine signaling 4 in biliary epithelial cells in response to Cryptosporidium parvum infection. J Infect Dis 2010, 202:125-135.
121. Zhou R, Gong AY, Eischeid AN, Chen XM miR-27b targets KSRP to coordinate TLR4-mediated epithelial defense against Cryptosporidium parvum infection. PLoS Pathog 2012, 8:e1002702.
122. Zhou R, Hu G, Liu J, Gong AY, Drescher KM, Chen XM NF-kappaB p65-dependent transactivation of miRNA genes following Cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog 2009, 5:e1000681.
123. McDonald V, Korbel DS, Barakat FM, Choudhry N, Petry F Innate immune responses against Cryptosporidium parvum infection. Parasite Immunol 2013, 35:55-64.
124. Dann SM, Wang HC, Gambarin KJ, et al. Interleukin-15 activates human natural killer cells to clear the intestinal protozoan cryptosporidium. J Infect Dis 2005, 192:1294-1302.
125. Robinson P, Okhuysen PC, Chappell CL, et al. Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine 2001, 15:39-46.
126. Choudhry N, Petry F, van Rooijen N, McDonald V A protective role for interleukin 18 in interferon γ-mediated innate immunity to Cryptosporidium parvum that is independent of natural killer cells. J Infect Dis 2012, 206:117-124.
127. Takeuchi D, Jones VC, Kobayashi M, Suzuki F Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum. Infect Immun 2008, 76:3657-3663.
128. Fan X, Upadhyaya B, Wu L, et al. CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clin Immunol 2012, 143:152-161.
129. Kirkpatrick BD, Haque R, Duggal P, et al. Association between Cryptosporidium infection and human leukocyte antigen class I and class II alleles. J Infect Dis 2008, 197:474-478.
130. White AC, Robinson P, Okhuysen PC, et al. Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J Infect Dis 2000, 181:701-709.
131. Pollok RC, Farthing MJ, Bajaj-Elliott M, Sanderson IR, McDonald V Interferon gamma induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology 2001, 120:99-107.
132. Pantenburg B, Castellanos-Gonzalez A, Dann SM, et al. Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells. Am J Trop Med Hyg 2010, 82:600-607.
133. Korpe PS, Liu Y, Siddique A, et al. Breast milk parasite-specific antibodies and protection from amebiasis and cryptosporidiosis in Bangladeshi infants: a prospective cohort study. Clin Infect Dis 2013, 56:988-992.
134. Moss DM, Chappell CL, Okhuysen PC, et al. The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis 1998, 178:827-833.
135. Sheoran A, Wiffin A, Widmer G, Singh P, Tzipori S Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum. J Infect Dis 2012, 205:1019-1023.
136. Preidis GA, Wang HC, Lewis DE, et al. Seropositive human subjects produce interferon gamma after stimulation with recombinant Cryptosporidium hominis gp15. Am J Trop Med Hyg 2007, 77:583-585.
137. Allison GM, Rogers KA, Borad A, et al. Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. Am J Trop Med Hyg 2011, 85:97-104.
138. Burton AJ, Nydam DV, Jones G, et al. Antibody responses following administration of a Cryptosporidium parvum rCP15/60 vaccine to pregnant cattle. Vet Parasitol 2011, 175:178-181.
139. Wang C, Luo J, Amer S, et al. Multivalent DNA vaccine induces protective immune responses and enhanced resistance against Cryptosporidium parvum infection. Vaccine 2010, 29:323-328.
140. Hong-Xuan H, Lei C, Cheng-Min W, et al. Expression of the recombinant fusion protein CP15-23 of Cryptosporidium parvum and its protective test. J Nanosci Nanotechnol 2005, 5:1292-1296.
141. Sagodira S, Buzoni-Gatel D, Iochmann S, Naciri M, Bout D Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA. Vaccine 1999, 17:2346-2355.
142. Roche JK, Rojo AL, Costa LB, et al. Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion. Vaccine 2013, 31:912-918.
143. Manque PA, Tenjo F, Woehlbier U, et al. Identification and immunological characterization of three potential vaccinogens against Cryptosporidium species. Clin Vaccine Immunol 2011, 18:1796-1802.
144. Borad AJ, Allison GM, Wang D, et al. Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh. Am J Trop Med Hyg 2012, 86:214-222.
145. Ehigiator HN, Romagnoli P, Priest JW, Secor WE, Mead JR Induction of murine immune responses by DNA encoding a 23-kDA antigen of Cryptosporidium parvum. Parasitol Res 2007, 101:943-950.
146. Benitez AJ, McNair N, Mead JR Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice. Clin Vaccine Immunol 2009, 16:1272-1278.
147. Lai O, Morris C, Ahmed S, et al. Serum antibody responses to polymorphic Cryptosporidium mucin antigen in Bangladeshi children with cryptosporidiosis. Am J Trop Med Hyg 2011, 85:464-470.
148. Benitez A, Priest JW, Ehigiator HN, McNair N, Mead JR Evaluation of DNA encoding acidic ribosomal protein P2 of Cryptosporidium parvum as a potential vaccine candidate for cryptosporidiosis. Vaccine 2011, 29:9239-9245.
149. Platts-Mills JA, Liu J, Houpt ER New concepts in diagnostics for infectious diarrhea. Mucosal Immunol 2013, 6:876-885.
150. Castellanos-Gonzalez A, Cabada MM, Nichols J, Gomez G, White AC Human primary intestinal epithelial cells as an improved in vitro model for Cryptosporidium parvum infection. Infect Immun 2013, 81:1996-2001.